Peter Attia· MD
cml chronic myeloid leukemia this is the gleevec story that i think is transformative some will argue is not cancer right away the skeptic would say is this a cancer right i mean it's a very fair point which is that what is cml it is a blood-based cancer one of the things about blood-based cancers is you tend to see that a lot sooner than you see other cancers because it's easy to find because it's in your blood you can just draw the blood and there it is and if you have that access to every organ in the same way maybe you'd be finding similar malignant lesions in other organs that's a possibility we also know it's genomically dumb it's driven by bcr able fusion a genomic event and not a whole heck of a lot else if that's the sole driver and if you give a drug that inhibits that fusion event you can turn median life expectancy from three to four years to nearly normal life expectancy in a swedish data set they're living almost a full life maybe a year shy of normal life expectancy that is a tremendous advance in medicine